Emerg Infect Dis. 2024 Nov;30(11):2429-2432. doi: 10.3201/eid3011.231393.
In Slovenia, primary acellular pertussis vaccines (ACVs) containing pertactin (PRN) were mostly used during 1999-2016; ACVs without PRN were introduced in 2017. Among 123 Bordetella pertussis strains collected during 2002-2020, a total of 48 were PRN-deficient; 44 were collected after 2017. Changes to ACVs could increase PRN-deficient B. pertussis and infections.
在斯洛文尼亚,1999 年至 2016 年期间主要使用含有百日咳丝状血凝素(PRN)的单价无细胞百日咳疫苗(ACV);2017 年引入了不含 PRN 的 ACV。在 2002 年至 2020 年间收集的 123 株百日咳博德特氏菌中,共有 48 株 PRN 缺失;其中 44 株是在 2017 年后收集的。ACV 的变化可能会增加 PRN 缺失的百日咳博德特氏菌和感染。